Genetic control of anti-thyrotropin receptor antibody generation in H- 2(K) mice immunized with thyrotropin receptor-transfected fibroblasts

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 12, 1997, Pages 4266-4269

  Yamaguchi, Ken Ichi ^a   Shimojo, Naoki ^a   Kikuoka, Shuichi ^a   Hoshioka, Akira ^a   Hirai, Aizan ^a   Tahara, Kazuo ^a   Kohn, Leonard D ^b   Kohno, Yoichi ^a   Niimi, Hiroo ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; THYROGLOBULIN ANTIBODY; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENETIC REGULATION; GENETIC TRANSFECTION; GRAVES DISEASE; HAPLOTYPE; HYPERTHYROIDISM; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; MURINAE;

EID: 0030786811     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.12.4589     Document Type: Article

References (21)

1. Kohn LD, Giuliani C, Montani V, et al. 1995 in Thyroid Immunity, eds. Rayner, D. and Champion, B., RG Landes Biomedical Publishers, TX, 115-170.
2. Shimojo N, Kohno Y, Yamaguchi K et al. 1996 Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc. Natl. Acad. Sci. USA 93: 11074-11079.
3. Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M 1983 Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet II (8359): 1115-1119.
4. Seetharamaiah GS, Desai RK, Dallas JS, Tahara K, Kohn LD, Prabhakar BS 1993 Induction of TSH binding inhibitory immunoglobulins with the extracellular domain of human thyrotoropin receptor produced using baculovirus expression system. Autoimmunity 14: 315-320.
5. Costagliola S, Alcalde L, Ruf J, Vassart G, Ludgate M 1994 Overexpression of the extracellular domain of the thyrotropin receptor in bacteria; production of thyrotrophin-binding inhibiting immunoglobulins. J. Mol. Endocrinol. 13: 11-21.
6. Costagliola S, Many MC, Stalmans-Falys M, Tonacchera M, Vassart G, Ludgate M 1994 Recombinant thyrotropin receptor and the induction of autoimmune thyroid disease in BALB/c mice: A new animal model. Endocrinology 135: 2150-2159.
7. Marion S, Braun JM, Ropars A, Kohn LD, Charreire J 1994 Induction of autoimmunity by immunization of mice with human thyrotropin receptor. Cell. Immunol. 158: 329-341.
8. Wagle NM, Dallas JS, Seetharamaiah GS, et al. 1994 Induction of hyperthyroxinemia in BALB/C but not in several other strains of mice. Autoimmunity 18: 103-112.
9. Tomer Y, Barbesino G, Greenberg D, Davis TF. 1997 The immunogenetics of autoimmune diabetes and autoimmune thyroid disease. Trends Endocrinol. Metab. 8: 63-70.
10. McAleer MA, Reifsnyder P, Palmer SM, et al. 1995 Crosses of NOD mice with the related NON strain. A polygenic model for IDDM. Diabetes 44: 1186-1195.
11. Serreze DV, Prochazka M, Reifsnyder PC, Bridgett MM, Leiter EH 1994 Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J. Exp. Med. 180: 1553-1558.
12. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR 1985 In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N. Engl. J. Med. 313: 353-360.
13. Sospedra M, Obiols G, Babi LF, et al. 1995 Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect ? J. Immunol. 154: 4213-4222.
14. Orgiazzi J, Williams DE, Chopra IJ, Solomon, DH. 1976 Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease. J. Clin. Endocrinol. Metab. 42: 341-354.
15. Endo K, Kasagi K, Konishi J, et al. 1978 Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. J. Clin. Endocrinol. Metab. 46: 734-739.
16. Valente WA, Vitti P, Yavin Z, et al. 1982 Monoclonal antibodies to the thyrotropin receptor: Stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. Proc. Natl. Acad. Sci., USA 79: 6680-6684.
17. Kohn LD, Alvarez F, Marcocci C, et al. 1986 Monoclonal antibody studies defining the origin and properties of autoantibodies in Graves' disease. Ann. NY Acad. Sci. 475: 157-173.
18. Yokoyama N, Izumi M, Katamine S, Nagataki S 1987 Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection. J. Clin. Endocrinol. Metab. 64: 215-218.
19. Okuda J, Akamizu T, Sugawa H, Matsuda F, Li H, Mori T 1994 Preparation and characterization of monoclonal antithyrotropin receptor antibodies obtained from peripheral lymphocytes of hypothyroid patients with primary myxedema. J. Clin. Endocrinol. Metab. 79: 1600-1604.
20. Kohn LD, Hoffman WH, Tombaccini D, et al. 1997 Characterization of monoclonal thyroid stimulating and thyrotropin binding inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease. J. Clin. Endocrinol. Metab in press.
21. Malnati MS, Marti M, LaVaute T, et al. 1992 Processing pathways for presentation of cytosolic antigen to MHC class II - restricted T cells. Nature 357: 702-704.